SpyGlass Pharma (SGP) Misses Q4 EPS by 572c
Tweet
Share
E-mail
Get Alerts SGP Hot Sheet
Join SI Premium – FREE
SpyGlass Pharma (NASDAQ: SGP) reported Q4 EPS of ($5.72).
For earnings history and earnings-related data on SpyGlass Pharma (SGP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Downgrades Logitech International (LOGI) to Underperform
- BofA Securities Reiterates Buy Rating on Chewy Inc. (CHWY)
- Evercore ISI Upgrades Owens Corning (OC) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
